NovellusDx Tissue Collection Protocol
Completed
- Conditions
- Patients Eligible for Tumor BiopsyPatients That Have Been Diagnosed With Colorectal Cancer
- Registration Number
- NCT01791322
- Lead Sponsor
- Fore Biotherapeutics
- Brief Summary
NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Patients that have been diagnosed positive for colon cancer.
- available treatment follow up during cancer treatment
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correct identification of tumor mutant genes up to 12 month Correct identification of tumor mutant genes, in over 85% of the cases
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does NovellusDx's diagnostic platform detect in colorectal cancer patient tumor tissues?
How does the chip-based mutation sensing technology in NCT01791322 compare to traditional biomarker assays for CRC patient stratification?
What activating mutations in colorectal cancer are most effectively monitored by NovellusDx's diagnostic device for personalized therapy selection?
Are there established adverse event profiles for diagnostic-driven treatment approaches in post-surgical CRC patients using similar technologies?
What combination therapies or targeted agents are being explored alongside NovellusDx's platform for RAS/RAF pathway-mutant colorectal cancer subtypes?
Trial Locations
- Locations (1)
Pathology Lab Hadassah Medical Center
🇮🇱Jerusalem, Israel
Pathology Lab Hadassah Medical Center🇮🇱Jerusalem, Israel